US 2021/0220381 A1Published application

A topoisomerase inhibitor for mimicking the effect of ionizing radiations on t cells

AssigneeNovagray

InventorsAdeline TORRO, Clémence FRANC

Life of this patent

Estimating the term…

Abstract

The present invention relates to a method for mimicking the effects of ionizing radiations on cells, wherein cells are contacted with a topoisomerase inhibitor.

Claims20

Dependent claims

An in vitro method for mimicking the effect of an ionizing radiation on T cells, comprising contacting said T cells with at least one inhibitor of topoisomerase.

Dependencies are inferred from the claim text.

Facts

Application: 15/734,319Filed 7 Jun 2019
Priority: EP 18305699.38 Jun 2018
Published: 22 Jul 2021
Term ends: Not estimatedThe source records don’t support an estimate.

Classification17 codes

A61K 31/7048
Compounds having saccharide radicals and heterocyclic rings: having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin,…
A61K 45/00
Medicinal preparations containing active ingredients not provided for in groups a61k31/00 -
A61K 31/335
Heterocyclic compounds: having oxygen as the only ring hetero atom, e.g. fungichromin
A61K 31/357
Having oxygen as the only ring hetero atom, e.g. fungichromin: having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

Family

US 12,070,470 B2Related patent
US 2021/0220381 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results